These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3700167)
1. Flow cytometry as a tool for the prognostic assessment of human neoplasia. Mauro F; Teodori L; Schumann J; Göhde W Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):625-36. PubMed ID: 3700167 [TBL] [Abstract][Full Text] [Related]
2. [Flow cytometric cell cycle analysis using a monoclonal antibody to bromodeoxyuridine on gastric cancers]. Ohyama S; Yonemura Y; Miyazaki I Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1848-54. PubMed ID: 2608014 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers. Ohyama S; Yonemura Y; Miyazaki I Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858 [TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma. Yonemura Y; Ooyama S; Sugiyama K; Kamata T; De Aretxabala X; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I Cancer Res; 1990 Feb; 50(3):509-14. PubMed ID: 2297693 [TBL] [Abstract][Full Text] [Related]
5. In vitro bromodeoxyuridine labeling of malignant neoplasms. A comparative study with flow cytometry cell-cycle analysis. Lloveras B; Garin-Chesa P; Myc A; Melamed M Am J Clin Pathol; 1994 Jun; 101(6):703-7. PubMed ID: 8209855 [TBL] [Abstract][Full Text] [Related]
6. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry. Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA/cytokeratin analysis of bladder lavage: methodical aspects and clinical implications. Liedl T Urol Int; 1995; 54(1):22-47. PubMed ID: 7770998 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers. Miyakawa A; Tachibana M; Tazaki H Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104 [TBL] [Abstract][Full Text] [Related]
9. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens. ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973 [TBL] [Abstract][Full Text] [Related]
10. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine. Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742 [TBL] [Abstract][Full Text] [Related]
11. Peripheral blood mononuclear cells are a reliable internal standard for the flow cytometric DNA analysis of frozen malignant breast biopsies. Benn DE; Robinson BG Cytometry; 1996 Jun; 26(2):161-5. PubMed ID: 8817093 [TBL] [Abstract][Full Text] [Related]
12. Characterization of ploidy level in bladder tumors and selected site specimens by flow cytometry. Jakobsen A; Mommsen S; Olsen S Cytometry; 1983 Sep; 4(2):170-3. PubMed ID: 6628139 [TBL] [Abstract][Full Text] [Related]
13. Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid tumors. Claud RD; Weinstein RS; Howeedy A; Straus AK; Coon JS Mod Pathol; 1989 Sep; 2(5):463-7. PubMed ID: 2813345 [TBL] [Abstract][Full Text] [Related]
14. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869 [TBL] [Abstract][Full Text] [Related]
15. Comparison of flow cytometric DNA content analysis of fresh and formalin-fixed paraffin-embedded solid neoplasms. Kumar D; Kumar S; Lyon D Mod Pathol; 1994 Apr; 7(3):354-60. PubMed ID: 8058708 [TBL] [Abstract][Full Text] [Related]
16. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data. Teodori L; Trinca ML; Goehde W; Hemmer J; Salvati F; Storniello G; Mauro F Int J Cancer; 1990 Jun; 45(6):995-1001. PubMed ID: 2161804 [TBL] [Abstract][Full Text] [Related]
17. Cellular heterogeneity of DNA/total-protein content in human lung tumors, as determined by flow cytometry. Teodori L; Trinca ML; Salvati F; Berettoni L; Storniello G; Göhde W Int J Cancer; 1992 Apr; 50(6):845-53. PubMed ID: 1313397 [TBL] [Abstract][Full Text] [Related]
18. Cycling S-phase cells in animal and spontaneous tumours. I. Comparison of the BrdUrd and 3H-thymidine techniques and flow cytometry for the estimation of S-phase frequency. Langer EM; Röttgers HR; Schliermann MG; Meier EM; Miltenburger HG; Schumann J; Göhde W Acta Radiol Oncol; 1985; 24(6):545-8. PubMed ID: 3006444 [TBL] [Abstract][Full Text] [Related]
19. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors. Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496 [TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples. Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]